tiprankstipranks
Dianthus Therapeutics (DE:87E)
XETRA:87E
Germany Market
87E
Dianthus Therapeutics
RESEARCH TOOLSreports

Dianthus Therapeutics (87E) Stock News & Sentiment

0 Followers
Dianthus Maintained at Buy as Strong Cash Runway and DNTH312 Pipeline Potential Support Unchanged $125 Price Target
Premium
Ratings
Dianthus Maintained at Buy as Strong Cash Runway and DNTH312 Pipeline Potential Support Unchanged $125 Price Target
1M ago
DNTH
Dianthus Advances Claseprubart Into Phase 3 EMERGE Trial, Raising Stakes in the Myasthenia Gravis Market
Premium
Company Announcements
Dianthus Advances Claseprubart Into Phase 3 EMERGE Trial, Raising Stakes in the Myasthenia Gravis Market
2M ago
DNTH
Dianthus Highlights Positive CAPTIVATE Phase 3 Interim Results
Premium
Company Announcements
Dianthus Highlights Positive CAPTIVATE Phase 3 Interim Results
3M ago
8K
DNTH
Analyst Maintains Buy Rating on Claseprubart Developer, Keeps $125 Price Target Unchanged Amid Confidence in Trial Design and Potency
Premium
Ratings
Analyst Maintains Buy Rating on Claseprubart Developer, Keeps $125 Price Target Unchanged Amid Confidence in Trial Design and Potency
3M ago
DNTH
Analyst Reiterates Buy on Dianthus Therapeutics, Keeping $130 Price Target Amid Confidence in Claseprubart’s Best-in-Class Potential
Premium
Ratings
Analyst Reiterates Buy on Dianthus Therapeutics, Keeping $130 Price Target Amid Confidence in Claseprubart’s Best-in-Class Potential
3M ago
DNTH
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
Premium
Company Announcements
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
4M ago
8K
DNTH
Dianthus Therapeutics: Best-in-Class C1s Antibody Claseprubart and Strong Execution Support Outperform Rating
Premium
Ratings
Dianthus Therapeutics: Best-in-Class C1s Antibody Claseprubart and Strong Execution Support Outperform Rating
5M ago
DNTH
More DE:87E News >

87E News on the Web

Fairmount Funds Management LLC Exits Apogee Therapeutics Inc (APGE) Position Entirely
GuruFocus News
Neutral
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
Insider Monkey
Neutral
Why Dianthus Therapeutics’ Hot Rally Is Suddenly Fading
TipRanks News
Neutral
New Autoimmune Drug Sends Dianthus Therapeutics Soaring
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)
TipRanks News
Bullish
Top Executive Makes Bold Move With Major Dianthus Therapeutics Stock Sale
TipRanks News
Neutral
DNTH SWOT Analysis: Financial Strength and Overvaluation Concerns Revealed in 10-Q Filing
GuruFocus News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Tyra Bioscience (TYRA)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:87E
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:87E’s Media Buzz Sentiment?
5 articles about DE:87E were published this week. In an average week, 2.75 articles are published.
    What is DE:87E’s weekly average amount of articles?
    In an average week, 2.75 articles about DE:87E are published.
      What is DE:87E’s News Sentiment?
      100% of articles about DE:87E were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        KURAKura Oncology
        AXGNAxoGen
        IRONDisc Medicine
        XERSXeris Pharmaceuticals
        LFSTLifestance Health Group
        Showing the stocks with the most bullish news sentiment over the past week